Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 6 |
NetGPI | no | yes: 0, no: 6 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005737 | cytoplasm | 2 | 1 |
GO:0005930 | axoneme | 2 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 1 |
Related structures:
AlphaFold database: E9AMN7
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 127 | 131 | PF00656 | 0.384 |
CLV_NRD_NRD_1 | 67 | 69 | PF00675 | 0.506 |
CLV_PCSK_KEX2_1 | 67 | 69 | PF00082 | 0.506 |
CLV_PCSK_SKI1_1 | 148 | 152 | PF00082 | 0.500 |
CLV_PCSK_SKI1_1 | 169 | 173 | PF00082 | 0.369 |
CLV_PCSK_SKI1_1 | 47 | 51 | PF00082 | 0.512 |
DEG_SPOP_SBC_1 | 180 | 184 | PF00917 | 0.304 |
DOC_CDC14_PxL_1 | 150 | 158 | PF14671 | 0.304 |
DOC_CYCLIN_RxL_1 | 164 | 173 | PF00134 | 0.325 |
DOC_CYCLIN_RxL_1 | 44 | 54 | PF00134 | 0.493 |
DOC_MAPK_MEF2A_6 | 195 | 204 | PF00069 | 0.284 |
DOC_MAPK_MEF2A_6 | 99 | 107 | PF00069 | 0.409 |
DOC_PP4_FxxP_1 | 151 | 154 | PF00568 | 0.363 |
DOC_USP7_MATH_1 | 18 | 22 | PF00917 | 0.627 |
DOC_USP7_MATH_1 | 6 | 10 | PF00917 | 0.582 |
LIG_14-3-3_CanoR_1 | 124 | 132 | PF00244 | 0.388 |
LIG_14-3-3_CanoR_1 | 195 | 204 | PF00244 | 0.417 |
LIG_14-3-3_CanoR_1 | 22 | 31 | PF00244 | 0.543 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.671 |
LIG_BIR_III_4 | 130 | 134 | PF00653 | 0.382 |
LIG_eIF4E_1 | 197 | 203 | PF01652 | 0.325 |
LIG_EVH1_2 | 154 | 158 | PF00568 | 0.304 |
LIG_FHA_1 | 181 | 187 | PF00498 | 0.451 |
LIG_FHA_1 | 51 | 57 | PF00498 | 0.503 |
LIG_FHA_2 | 22 | 28 | PF00498 | 0.583 |
LIG_Pex14_2 | 145 | 149 | PF04695 | 0.514 |
LIG_Pex14_2 | 158 | 162 | PF04695 | 0.304 |
LIG_SH2_CRK | 140 | 144 | PF00017 | 0.446 |
LIG_SH2_CRK | 197 | 201 | PF00017 | 0.304 |
LIG_SH2_STAP1 | 197 | 201 | PF00017 | 0.284 |
LIG_SH2_STAT3 | 191 | 194 | PF00017 | 0.325 |
LIG_SUMO_SIM_anti_2 | 198 | 209 | PF11976 | 0.284 |
LIG_SUMO_SIM_par_1 | 200 | 209 | PF11976 | 0.436 |
LIG_TRAF2_1 | 58 | 61 | PF00917 | 0.480 |
MOD_CK1_1 | 125 | 131 | PF00069 | 0.334 |
MOD_CK1_1 | 21 | 27 | PF00069 | 0.666 |
MOD_CK1_1 | 92 | 98 | PF00069 | 0.628 |
MOD_CK2_1 | 21 | 27 | PF00069 | 0.594 |
MOD_CK2_1 | 38 | 44 | PF00069 | 0.394 |
MOD_CK2_1 | 55 | 61 | PF00069 | 0.507 |
MOD_GlcNHglycan | 1 | 4 | PF01048 | 0.519 |
MOD_GlcNHglycan | 124 | 127 | PF01048 | 0.501 |
MOD_GlcNHglycan | 197 | 200 | PF01048 | 0.351 |
MOD_GSK3_1 | 1 | 8 | PF00069 | 0.665 |
MOD_GSK3_1 | 18 | 25 | PF00069 | 0.490 |
MOD_GSK3_1 | 202 | 209 | PF00069 | 0.329 |
MOD_NEK2_1 | 1 | 6 | PF00069 | 0.717 |
MOD_NEK2_1 | 202 | 207 | PF00069 | 0.498 |
MOD_PKA_2 | 21 | 27 | PF00069 | 0.565 |
TRG_DiLeu_BaEn_1 | 52 | 57 | PF01217 | 0.518 |
TRG_DiLeu_BaEn_3 | 165 | 171 | PF01217 | 0.278 |
TRG_DiLeu_BaEn_4 | 60 | 66 | PF01217 | 0.452 |
TRG_ENDOCYTIC_2 | 140 | 143 | PF00928 | 0.506 |
TRG_ENDOCYTIC_2 | 197 | 200 | PF00928 | 0.304 |
TRG_ER_diArg_1 | 67 | 69 | PF00400 | 0.506 |
TRG_Pf-PMV_PEXEL_1 | 169 | 173 | PF00026 | 0.325 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1PCZ4 | Leptomonas seymouri | 54% | 88% |
A0A3S7WQK8 | Leishmania donovani | 92% | 100% |
A4H5L1 | Leishmania braziliensis | 75% | 100% |
A4HTV0 | Leishmania infantum | 92% | 100% |
Q4QHY8 | Leishmania major | 89% | 100% |